An analyst sees good growth prospects for Wave Life Sciences Ltd (WVE)

With 1.48 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.94 million shares. The 52-week range on WVE shows that it touched its highest point at $16.74 and its lowest point at $4.25 during that stretch. It currently has a 1-year price target of $22.91. Beta for the stock currently stands at -1.11.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of WVE was down-trending over the past week, with a drop of -0.28%, but this was down by -10.88% over a month. Three-month performance dropped to -30.00% while six-month performance rose 84.15%. The stock gained 106.04% in the past year, while it has lost -14.55% so far this year. A look at the trailing 12-month EPS for WVE yields -0.79 with Next year EPS estimates of -0.98. For the next quarter, that number is -0.27. This implies an EPS growth rate of -40.82% for this year and 0.58% for next year. EPS is expected to grow by 4.92% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 34.27%.

Float and Shares Shorts:

At present, 153.04 million WVE shares are outstanding with a float of 122.14 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for WVE since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.85779 being high and -$1.36648 being low. For WVE, this leads to a yearly average estimate of -$1.13707. Based on analyst estimates, the high estimate for the next quarter is -$0.09 and the low estimate is -$0.29. The average estimate for the next quarter is thus -$0.24.

Summary of Insider Activity:

Insiders traded WVE stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.